These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Chemotherapy. Carbone PP Natl Cancer Inst Monogr; 1973 May; 36():357-8. PubMed ID: 4126719 [No Abstract] [Full Text] [Related]
4. [Cytostatic chemotherapy of lymphogranulomatosis]. Dold U Dtsch Med Wochenschr; 1978 Feb; 103(6):235-8. PubMed ID: 75085 [No Abstract] [Full Text] [Related]
5. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas]. Klein HO Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808 [No Abstract] [Full Text] [Related]
9. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal. DeVita VT Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596 [No Abstract] [Full Text] [Related]
10. The treatment of Hodgkin's disease. Fairley GH Trans Med Soc Lond; 1972; 88():61-71. PubMed ID: 4665820 [No Abstract] [Full Text] [Related]
11. Progress in the chemotherapy of hematologic diseases. Frei E Bibl Haematol; 1975; (40):27-43. PubMed ID: 51622 [TBL] [Abstract][Full Text] [Related]
12. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease]. Aghai E; Kende G; Many A; Ramot B Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045 [No Abstract] [Full Text] [Related]
13. Splenectomy effects on chemotherapy in Hodgkin's disease. Panettiere F; Coltman CA Arch Intern Med; 1973 Mar; 131(3):362-6. PubMed ID: 4688035 [No Abstract] [Full Text] [Related]
14. Status and perspectives in chemotherapy of Hodgkin's disease. Frei E Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436 [No Abstract] [Full Text] [Related]
15. Hodgkin disease with acute lymphoblastic leukemia. Grant MD; Coleman M JAMA; 1975 Feb; 231(6):623. PubMed ID: 1054100 [No Abstract] [Full Text] [Related]
17. [Polychemotherapy of Hodgkin's disease. Long-term results in 226 cases]. Jacquillat C; Auclerc G; Gemon-Auclerc MF; Weil M; Chastang C; Boiron M; Bernard J Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):473-83. PubMed ID: 917836 [No Abstract] [Full Text] [Related]
18. The sensitivity of Hodgkin's disease to chemotherapeutic agents administered singly. Desser RK; Ultmann JE Ser Haematol; 1973; 6(2):152-81. PubMed ID: 4131662 [No Abstract] [Full Text] [Related]
19. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow]. Fiacchini M; Lauria F; Mazza P; Tura S Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996 [No Abstract] [Full Text] [Related]
20. [Chemotherapy of Hodgkin disease with modified MOPP]. Amiel JL; Spielmann M; Kerbrat P; Droz JP; Tursz T; Ben Ayed F Schweiz Rundsch Med Prax; 1983 Feb; 72(6):190-3. PubMed ID: 6687638 [No Abstract] [Full Text] [Related] [Next] [New Search]